ÈÊÐÅ²ÊÆ±¹ÙÍø

ÈÊÐÅ²ÊÆ±¹ÙÍø£¨¹ÉƱ´úÂ룺002821.SZ/6821.HK£©

¹ØÓÚÈÊÐÅ²ÊÆ±¹ÙÍø-Áìµ¼ÍŶÓ

ºËÐĹÜÀíÍŶÓ

Core
Management
Team
  • ÑîÈï

    Co-CEO

    ÓµÓжþÊ®¶àÄêµÄ¼¯ÍÅÔËÓª¹ÜÀí¡¢Êг¡¿ªÍØ¡¢ÈËÁ¦×ÊÔ´¹ÜÀí¡¢ÏîÄ¿¹ÜÀí¡¢²ÆÎñ¹ÜÀí¡¢¹«¹²ÊÂÒµ¹ÜÀíµÈ¾­Ñ顣ͳ³ïÁìµ¼ÉúÎï´ó·Ö×Ó¡¢ÁÙ´²CROµÈÕ½ÂÔÐÂÐËÊÂҵȺ·¢Õ¹£¬³ÖÐøÍÆ¶¯¹«Ë¾GXPһվʽ·þÎñƽ̨·¢Õ¹£¬²¢Ö§³ÖÈÊÐÅ²ÊÆ±¹ÙÍøÕûÌåÔËÓª¹¤×÷£¬ÖúÁ¦ ¡°Ë«ÂÖÇý¶¯¡±Õ½ÂÔÓÐЧÂ䵨¡£ÓÚ±±¾©´óѧ»ñµÃEMBAѧλ¡£

  • ÕÅ´ï

    COO

    ÓµÓг¬¹ýÊ®ÎåÄêÆóÒµÔËÓª¹ÜÀí¡¢Í¶ÈÚ×ʺͲÆÎñ¹ÜÀíµÈ·½Ãæ¾­Ñé¡£È«ÃæÁìµ¼ºÍ¸ºÔðÈÊÐÅ²ÊÆ±¹ÙÍøÔËÓª¹ÜÀíÏà¹ØÕ½ÂÔʵʩ£¬Í¬Ê±Í³³ï²ÆÎñ¹ÜÀí¡¢Í¶ÈÚ×Ê¡¢ÊÐÖµ¹ÜÀíµÈ¡£ÓÚÇ廪ÎåµÀ¿Ú½ðÈÚѧԺ»ñµÃ½ðÈÚѧ˶ʿѧλ¡£

  • ³Â³ÏÒå

    CTO

    ÓµÓзḻµÄÖÆÒ©Ñз¢£¬Éú²úÒÔ¼°¼à¹ÜÉ걨µÈ¾­Ñé¡£ÔøÔÚĬ¿Ë¡¢Ç¿Éú¡¢Mirati Therapeutics ºÍ°ÙʱÃÀÊ©¹ó±¦µÈÖªÃû¹«Ë¾´ÓÊÂÏà¹Ø¹¤×÷¡£Í³³ïÁìµ¼ÈÊÐÅ²ÊÆ±¹ÙÍø¼¼ÊõÑз¢ÒÔ¼°Ö§³Ö¼¯ÍÅÏà¹ØÒµÎñÏúÊÛ¡£Áìµ¼ÍÆ½øÖصãÏîÄ¿ÒÔ¼°¹Ø¼ü¿Í»§ºÏ×÷¡£ÓÚ¶íº¥¶íÖÝÁ¢´óѧ»ñµÃÓлú»¯Ñ§²©Ê¿Ñ§Î»¡£

  • ºéÁÁ

    Ö´Ðи±×ܲÃ

    ÓµÓжþÊ®ÓàÄêµÄ´óÐÍн¨³§Çø¡¢ÐÂÐÍÒµÎñ³µ¼ä¡¢Ïà¹ØÉèÊ©µÄÕûÌ幤³Ì¹ÜÀí¾­Ñ飬²¢ÔÚ¹«Ë¾Íâ°ü¹©Ó¦Á´´î½¨¼°¹ÜÀí£¬ÒÔ¼°Á¬Ðø·´Ó¦¼¼ÊõÖÐÐÄ×ÛºÏÔËÓª¹ÜÀíµÈ·¢»ÓÖØÒª×÷Óá£È«ÃæÁìµ¼ÈÊÐÅ²ÊÆ±¹ÙÍø¹¤³Ì½¨Éè¡¢°²×°¡¢Íâ°ü¹©Ó¦Á´¹ÜÀíÒÔ¼°Á¬Ðø¿ÆÑ§¼¼ÊõÖÐÐĹÜÀí¹¤×÷¡£

  • ³Â³¯ÓÂ

    Ö´Ðи±×ܲÃ

    ÓµÓжþÊ®ÓàÄêÖÆÒ©Ñз¢Éú²ú¾­Ñ飬ÔÚ¸ßÄѶÈÖÆÒ©¿ª·¢ÏîÄ¿ºÍÉú²úÏîÄ¿Öз¢»ÓÁËÖØÒªµÄ×÷Óã¬Íƶ¯¹«Ë¾ÉÌÒµ»¯Éú²úÏîÄ¿µÄ¼¼ÊõˮƽºÍÄÜÁ¦³ÖÐøÌáÉý¡£×÷ΪÖ÷Òª·¢Ã÷ÈËÖ®Ò»£¬²ÎÓëÁ˹«Ë¾ÊýÊ®Ïî¹ú¼Ê¡¢¹úÄÚ·¢Ã÷רÀûµÄÉêÇë¡£Áìµ¼ºÍÖ§³Ö¼¯ÍŹؼüÏîÄ¿µÄÉÌÒµ»¯¿ª·¢£¬¼¼Êõ×ªÒÆºÍÉú²úµÈ£¬È·±£ÒµÎñÁìÓòÕ½ÂÔʵʩ¡£

  • ½ªÓ¢Î°

    Ö´Ðи±×ܲÃ

    ÓµÓм¯ÍÅÕ½ÂԹܿØ¡¢¼¯ÍÅ»¯×éÖ¯ÓëÈËÁ¦×ÊÔ´¹ÜÀí¡¢¼¯ÍÅ»¯ÐÐÕþÓëºóÇÚ¹ÜÀíµÈÁìÓò¾ßÓзḻµÄ¹ÜÀí¾­Ñé¡£È«ÃæÁìµ¼ºÍ¸ºÔðÈÊÐÅ²ÊÆ±¹ÙÍø×éÖ¯ÓëÈËÁ¦×ÊÔ´·¢Õ¹Õ½ÂÔµÄÖÆ¶¨Óëʵʩ¡£¸ù¾Ý¼¯ÍÅ·¢Õ¹Õ½ÂÔ£¬ÓÅ»¯µ÷ÕûºÍ±£Õϼ¯ÍÅ×éÖ¯ºÍÈËÁ¦×ÊÔ´¹ÜÀíÕ½ÂÔµÄʵʩ¡£ÓÚ±±¾©´óѧ¹â»ª¹ÜÀíѧԺ»ñµÃ¹¤É̹ÜÀí˶ʿѧλ¡£

  • Ö£¹úϲ

    ¸ß¼¶¸±×ܲÃ

    ÓµÓг¬25ÄêÔ­ÁÏÒ©ºÍÖÆ¼Á½¨Éè¡¢Ñз¢¡¢Éú²ú¼°ÔËÓª¹ÜÀí¾­Ñ飬ÊìϤŷÃÀ¼°ÖйúGMP·¨¹æºÍÖ¸ÄÏ£¬¶Ô¸÷Àà¹Ù·½Éó¼ÆÓÐ×ŷḻµÄʵ¼ù¾­Ñ飬Éó¤¸ÄÔìÏÖÓÐÉèÊ©ÌáÉýÖÁ×îÏȽøµÄGMPÓë°²»·ÎÀ±ê×¼£¬Íƶ¯Lean and Six SigmaÊÖ·¨ÒÔ¸ÄÉÆ»òÓÅ»¯Éú²úЧÂÊ£¬¾«Í¨¸ß»îÐÔÒ©Îï·À»¤¼¼ÊõÓ뽡¿µ·çÏÕÆÀ¹ÀºÍ¹ÜÀí¡£Áìµ¼ºÍÖ§³ÖÈÊÐÅ²ÊÆ±¹ÙÍøÅ·ÖÞ¼°²¿·ÖÖйúµØÇøÑз¢Éú²ú»ùµØ½¨Éè¼°ÔËÓª¹ÜÀí£¬Í³³ï¼¯ÍÅÖ°Òµ½¡¿µ°²È«¹ÜÀíÕ½ÂÔʵʩ¡£ÓÚÔ¼º²Ë¹»ôÆÕ½ð˹´óѧ»ñµÃ²©Ê¿Ñ§Î»¡£

  • ÖÜÑ×

    ¸ß¼¶¸±×ܲÃ

    ÉîÚÏÒ©Æ·Ñз¢µ½ÉÌÒµ»¯Éú²úµÄ¹ÜÀíºÍ·¨¹æÐèÇ󣬼«¸»ÖÆÒ©¹¤³§ÖÊÁ¿¹ÜÀí¾­Ñé¡£ÏȺó´ÓÊ»¯Ñ§Ô­ÁÏÒ©µÄ¹¤ÒÕ¿ª·¢Ó빤ÒÕ×ªÒÆÑо¿£¬¹¤ÒÕÑéÖ¤ÒÔ¼°³ÖÐøµÄÉÌÒµ»¯Éú²ú¡£ÎªÈÊÐÅ²ÊÆ±¹ÙÍø½¨Á¢Å·ÃË¡¢ÃÀ¹ú¡¢°ÄÖÞ¡¢ÖйúÒÔ¼°ÈÕ±¾µÈ¹ú¼ÒÏȽøcGMPÒªÇóµÄÖÊÁ¿¹ÜÀíÌåϵ½¨Éè·¢»ÓÖØÒª×÷Óá£Ö÷³Ö¹ý¶à¸ö¹ú¼Ò¹Ù·½Ò©¼à»ú¹¹ÔÚ´´ÐÂÒ©ÉóÅúǰ£¨PAI£©ÒÔ¼°ÉóÅúºóµÄÏÖ³¡»òÕßÔ¶³ÌÖÊÁ¿É󼯣¬ÖúÁ¦¹úÄÚÍâ¿Í»§Ê®Óà¿î´´ÐÂÒ©ÉÏÊнø³Ì¡£È«ÃæÁìµ¼ÈÊÐÅ²ÊÆ±¹ÙÍø¸²¸ÇÒ©Æ·ÉúÃüÖÜÆÚµÄÖÊÁ¿¹ÜÀí£¨QAºÍQC£©Õ½ÂÔÂ䵨Óëʵʩ¡£

  • Elut Hsu

    ¸ß¼¶¸±×ܲÃ

    ÓµÓÐÔÚ±±¿¨ÂÞÀ´ÄÉÖÝÁ¢´óѧºÍÏã¸Û¿Æ¼¼´óѧ3ÄêʵÑéÊÒÑо¿¾­Ñ飬¶ÔÏà¹Ø¼¼Êõ¼°ÔËÓª¹ÜÀíÓÐ×ŶÀµ½µÄ¼û½âºÍÈÏÖª¡£ÓµÓÐCDMOÁìÓò·þÎñÈ«ÇòÖÆÒ©ÐÐÒµ³¬25Äê¾­Ñé¡£¶ÔFDA ICH Q7£¬»¯Ñ§¼Ó¹¤ÒÔ¼°·¨ÂÉ/ÉÌÒµÀí½âÓнÏǿʵ¼ù֪ʶÓëÄÜÁ¦£¬ÒÔÖ§³Ö´ÓÁÙ´²¿ª·¢µ½ÉÌÒµ¹©Ó¦µÄÍêÕû·¾¶¡£È«ÃæÍ³³ïºÍÁìµ¼ÈÊÐÅ²ÊÆ±¹ÙÍøÎ»ÓÚÃÀ¹ú×ܲ¿µÄÔËÓªÕ½ÂÔÂ䵨£¬Ö§³Ö¼¯ÍÅÔÚÃÀ¸÷ÏîÒµÎñ¸ßЧ¿ªÕ¹¡£

  • »ÆÆ½ÖÒ

    ¸ß¼¶¸±×ܲÃ

    ÓµÓжàÄêÒ©ÎïÑз¢¹ÜÀí¾­Ñé£¬Ôø¾ÍÖ°ÓÚ»ÝÊϹ«Ë¾µÈÈ«ÇòÖªÃûÖÆÒ©Ïà¹ØÆóÒµ¡£Ö÷ÒªÁìµ¼ºÍÖ÷³ÖÈÊÐÅ²ÊÆ±¹ÙÍøÏà¹ØÏîÄ¿Ñз¢ÒÔ¼°ÏîÄ¿¹ÜÀíµÈ¹¤×÷£¬Í¬Ê±¸ºÔð¹«Ë¾ÔÚÃÀ¿Í»§µÄ¹ØÏµ¹ÜÀíºÍά»¤¡£ÓÚÈðÊ¿ÈÕÄÚÍß´óѧ»ñµÃ²©Ê¿Ñ§Î»¡£

  • Jon Brice

    ¸ß¼¶¸±×ܲÃ

    ÓµÓг¬¹ý25ÄêµÄ»¯Ñ§ÖÆÒ©Ñз¢ºÍÖÆÔìÐÐÒµÏà¹Ø¾­Ñé¡£¶Ô»¯Ñ§Æ·ÖÆÔìµÄÏȽø¼¼ÊõºÍÒµÎñÓÐ×ÅÉîÈëµÄÀí½âºÍÈÏʶ£¬ÔøÈÎÖ°ÓÚÑÅÅàʵÑéÊÒ¡¢°Ý¶ûºÍ°²½øµÈÖªÃûÆóÒµ¡£Ö÷ÒªÁìµ¼ºÍÍÆ½øÈÊÐÅ²ÊÆ±¹ÙÍøÓ뺣Íâ¸÷´óÐÍÖÆÒ©¹«Ë¾¡¢ÉúÎï¼¼Êõ¹«Ë¾ÉÌÎñÒµÎñÍùÀ´¼°ÏîÄ¿ºÏ×÷¡£ÓÚÒÁÀûŵÒÁ´óѧ¶ò°ÍÄÉ-ÏãéÄ·ÖУ»ñµÃ²©Ê¿Ñ§Î»¡£

  • ÐìÏò¿Æ

    ¸ß¼¶¸±×ܲü涭Ê»áÃØÊé

    ÓµÓжþÊ®ÓàÄêÆóÒµÔËÓª¹ÜÀí¾­Ñ飬½¨Á¢Óëά»¤Õþ¸®»ú¹¹¡¢¼à¹Ü²¿ÃÅ¡¢ÐÐҵЭ»á¡¢ÆóÊÂÒµµ¥Î»µÈÍⲿÏà¹Øµ¥Î»³¤ÆÚÁ¼ºÃ¹ØÏµ£¬ÔÚ²úÒµ¡¢È˲Å¡¢²ÆË°µÈÕþ²ßʵʩÓëÉ걨¡¢×ʱ¾Êг¡¼°Éç»á¹«ÖÚÁ¼ºÃÆ·ÅÆÐÎÏóÖз¢»ÓÖØÒª×÷Óᣳɹ¦Íƶ¯¹«Ë¾µÇ½¹ú¼Ê¹úÄÚ×ʱ¾Êг¡£¬Æ·ÅƼÛÖµ¼°ÐÎÏó³ÖÐøÎȲ½ÉÏÉý¡£È«ÃæÁìµ¼ºÍÖ÷³ÖÈÊÐÅ²ÊÆ±¹ÙÍøÕþ¸®ÊÂÎñ¡¢Ö¤È¯ÊÂÎñ¡¢¹«¹²ÊÂÒµµÈ¶àÁìÓòÔËÓª¹ÜÀí£¬Ö§³ÖÈ·±£¹«Ë¾¸÷ÏîÒµÎñ»î¶¯ºÏ¹æ¡¢¸ßЧ¡¢ÓÐÐòÍÆ½ø¡£ÓÚÉϺ£¸ß¼¶½ðÈÚѧԺ»ñµÃEMBAѧλ¡£

  • Ö£Ã÷ÖÇ

    ¸ß¼¶¸±×ܲÃ

    Ó¢Áª°î»¯Ñ§¹¤³ÌʦЭ»á£¨IChemE£© ÌØÐí»¯Ñ§¹¤³ÌʦCEng¡£ÓµÓжàÄ꺣Í⹤ÒÕ¹¤³Ì¼¼ÊõÑз¢£¬¹¤³ÌÉè¼Æ¼°ÏîÄ¿ºÍÍŶӹÜÀí¾­Ñé¡£ÔøÈÎÖ°ÓÚ¶à¼ÒÈ«Çò´óÐÍ»¯Ñ§Æ·ºÍÖÆÒ©¹«Ë¾¡£Áìµ¼ºÍ¸ºÔð¼¯ÍÅ»¯Ñ§¹¤³Ì¡¢ÖÇÄÜ»¯Êý×Ö»¯½¨ÉèµÈÁìÓòµÄÕ½ÂÔʵʩ¼°ÔËÓª¹ÜÀí¹¤×÷¡£ÓÚÓ¢¹ú½£ÇÅ´óѧ»ñµÃ²©Ê¿Ñ§Î»¡£

  • Ò¶Á¢ÎÄ

    ¸ß¼¶¸±×ܲÃ

    ÓµÓÐ30ÓàÄêÖÆÒ©ÐÐҵʵ¼ù¾­Ñ飬¾ß±¸·á¸»µÄÑз¢·ÖÎöרҵ±³¾°£¬ÎªÒ©Æ·¿ª·¢¡¢ÁÙ´²ºÍÉÌÒµ»¯ÔËÓªÌṩÓÐÁ¦Ö§³Ö¡£¾ßÓзḻµÄCGMP¹ÜÀíºÍÑз¢¡¢IND¡¢NDAºÍANDAÉêÇë¾­Ñ飬Éó¤ÁÙ´²Ç°ºÍÁÙ´²¹©Ó¦·ÅÐÐÓë¹ÜÀí¡£Áìµ¼ºÍ¸ºÔð¼¯ÍÅ»¯Ñ§Ð¡·Ö×Ó¡¢»¯Ñ§´ó·Ö×Ó¡¢ÖƼÁ¡¢ºÏ³ÉÉúÎïÒµÎñ·ÖÎöÑо¿Ó뿪·¢²¿£¨ARD£©µÄÕûÌåÒµÎñ¿ªÕ¹£¬Ö§³Ö¼¯ÍÅ·¢Õ¹Õ½ÂÔÄ¿±êʵʩ¡£ÓÚ¼ÓÄô󿨶û¼ÓÀï´óѧ»ñµÃ·ÖÎö»¯Ñ§²©Ê¿Ñ§Î»¡£

ÈÊÐÅ²ÊÆ±¹ÙÍøÒ½Ò©¼¯ÍÅ

µØÖ·: ÖйúÌì½òÊбõº£ÐÂÇøµÚÆß´ó½Ö71ºÅ

Óʱà:300457

×Ü»ú:022-66252888

´«Õæ:022-66252777

¹úÄÚÒµÎñ

BD@asymchem.com.cn

֤ȯÊÂÎñ

securities@asymchem.com.cn

Ͷ×ÊÕß¹ØÏµ

IR@asymchem.com.cn

HRÕÐÆ¸

hr@asymchem.com.cn

¼¯ÍŹٷ½Î¢ÐÅ
ÈËÁ¦×ÊԴ΢ÐÅ

ÓÑÇéÁ´½Ó:

Copyright ¡ò 2018 ÈÊÐÅ²ÊÆ±¹ÙÍøÒ½Ò©¼¯ÍÅ

·¨ÂÉÉùÃ÷

½òICP±¸13000103-1

½ò¹«Íø°²±¸12011602300556ºÅ

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿